Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07842523 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Obinutuzumab in Systemic Sclerosis

Name: Obinutuzumab in Systemic Sclerosis — clinical trial record (NCT07842523)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: OBINUSS

StatusNot Yet Recruiting

PhasePhase 2

SponsorAssistance Publique - Hôpitaux de Paris

Started2026-11

View on ClinicalTrials.gov ↗

Assistance Publique - Hôpitaux de Paris

1,338 trials monitored

See 38 trials at risk

Scleroderma

302 trials monitored

See 9 trials at risk

The purpose of this study is to determine if obinutuzumab is effective in systemic sclerosis

Trial Details

NCT Number	NCT07842523
Lead Sponsor	Assistance Publique - Hôpitaux de Paris Collaborators: URC-CIC Paris Descartes Necker Cochin
Conditions	Systemic Sclerosis in Adults
Enrollment	120 participants
Start Date	2026-11
Primary Completion	2029-12 (estimated)
Study Completion	2030-06 (estimated)
Updated on ClinicalTrials.gov	2026-09-25